Background
Dylan Skinner, a long-time registered personal medical cannabis producer, sought a judicial review of Health Canada’s decision to refuse the renewal of his registration. Concurrently, he filed a motion for an interlocutory injunction (a stay) to permit him to continue cultivating and possessing cannabis while his application for judicial review proceeded. Skinner argued that Health Canada’s refusal, based on alleged obstruction of inspectors, was flawed and that he faced irreparable harm without continued access to his specific medical cannabis supply.
Health Canada, the respondent, argued that Skinner was requesting a mandatory interlocutory injunction, which requires a higher legal threshold. They contended that Skinner had not satisfied any of the branches for such exceptional relief, emphasizing that the practical effect of his motion was to compel the Minister to allow him to produce cannabis despite his registration having expired.
The Court’s Holding
The Federal Court dismissed Skinner’s motion for injunctive relief, finding that he failed to meet the necessary criteria, particularly the elements of irreparable harm and balance of convenience. Applying the three-part test from RJR-MacDonald, and the higher threshold for mandatory interlocutory injunctions (requiring a strong prima facie case), the Court found that while Skinner raised arguments regarding the merits of his judicial review, it was not necessary to fully address the “strong prima facie case” branch, as he failed on the subsequent two.
Specifically, the Court ruled that Skinner did not demonstrate irreparable harm with “clear and non-speculative evidence.” His claims of health detriment and potential criminal charges if he continued production without a renewed registration were deemed general, uncorroborated, and based on risks already known and within his control. On the balance of convenience, the Court sided with the Attorney General, emphasizing the public interest in regulatory cases. An injunction would interfere with the Minister’s mandate to protect public health and safety under the Cannabis Act and Regulations, an interference which the Court is reluctant to permit, particularly at the interlocutory stage where the relief sought goes beyond what a judicial review would typically grant (i.e., setting aside and remitting for redetermination).
Key Takeaways
- Mandatory interlocutory injunctions, which seek to restore a prior state, face a higher legal bar, requiring a “strong prima facie case” for the underlying judicial review application.
- To prove irreparable harm for injunctive relief, applicants must provide detailed, concrete, and non-speculative evidence; hypothetical risks or those resulting from continued unlawful conduct are insufficient.
- In regulatory contexts, the public interest often weighs heavily against granting interlocutory injunctions that would prevent an administrative agency from fulfilling its statutory mandate to protect public health and safety.
- Courts are generally reluctant to intervene in the management of compliance and non-compliance by regulatory bodies through interlocutory injunctions.
Why It Matters
This decision underscores the high threshold applicants face when seeking extraordinary interim relief, like a mandatory interlocutory injunction, to challenge administrative decisions, especially in highly regulated sectors like medical cannabis. It reinforces that courts are reticent to micromanage regulatory compliance or to preemptively restore privileges that have been revoked, particularly when public health and safety mandates are involved. For individuals and businesses operating under federal regulations, it highlights the importance of rigorously demonstrating specific, non-speculative irreparable harm and carefully considering how the public interest might be framed in any request for interim relief during judicial review proceedings.